PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: UROLOGIC AND GYNECOLOGIC NEOPLASMS.
D000230:Adenocarcinoma; D000740:Anemia; D000741:Anemia, Aplastic; D000970:Antineoplastic Agents; D002294:Carcinoma, Squamous Cell; D004358:Drug Therapy; D005260:Female; D006801:Humans; D006918:Hydroxyurea; D007680:Kidney Neoplasms; D007970:Leukopenia; D008297:Male; D009369:Neoplasms / Q000453:epidemiology*; D011471:Prostatic Neoplasms; D013736:Testicular Neoplasms; D013921:Thrombocytopenia; D014116:Toxicology; D014510:Urease; D001749:Urinary Bladder Neoplasms; D002583:Uterine Cervical Neoplasms; D014594:Uterine Neoplasms
D000970:Antineoplastic Agents; D014510:Urease; D006918:Hydroxyurea
ADENOCARCINOMA; ANEMIA, APLASTIC; ANTINEOPLASTIC AGENTS; BLADDER NEOPLASMS; CARCINOMA, EPIDERMOID; CERVIX NEOPLASMS; DRUG THERAPY; KIDNEY NEOPLASMS; LEUKOPENIA; NEOPLASM STATISTICS; PROSTATIC NEOPLASMS; TESTICULAR NEOPLASMS; THROMBOPENIA; TOXICOLOGIC REPORT; UREASE; UTERINE NEOPLASMS